Civeo Corporation
NYSE:CVEOSpecialty Business Services
+$0.53 today
- Market cap
- $355.18M
- Beta
- 0.72
- P/E (TTM)
- -26.7
- EPS (TTM)
- -$1.26
Volume 0.09M
Average 0.07M
CVEO Financing Cash Flow
Net cash exchanged with lenders and shareholders through borrowing, repayments, buybacks, and dividends.
Civeo CorporationNYSE: CVEO
Financing Cash Flow · Q1 FY2026 · quarter ended Mar 2026
Financing cash flow dips below year-ago levels
Q1 FY2026 financing cash flow of $15.87M fell 56.7% year over year, behind the +253.4% change in trailing-twelve-month financing cash flow.
Context
- Financing cash flow amounted to 11.7% of revenue in FY2025, up 2.1 pp from a year earlier.
- Financing cash flow increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from -56.7% toward the trailing-twelve-month pace of +253.4%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Financing Cash Flow history
USD · from the cash flow
- Latest · FY2025
- 74.72M USD
- Year-over-year change
- +214.6%
| Period | Period end | Financing Cash Flow | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 74.72M | +214.6% |
| FY2024 | 2024-12-31 | (65.2M) | +24.9% |
| FY2023 | 2023-12-31 | (86.8M) | -9.0% |
| FY2022 | 2022-12-31 | (79.66M) | +7.9% |
| FY2021 | 2021-12-31 | (86.51M) | — |
Financing Cash Flow vs competitors
How CVEO compares with its peers on the latest reported figures
- CVEO's LTM Mar 2026 financing cash flow of $53.96M is the 4th largest of the 11 companies compared; the peer median is $25.18M.
- Its year-over-year change of +253.4% is the 2nd highest of 10, against a peer median of -45.2%.
- Financing cash flow amounts to 8.1% of revenue for CVEO, versus a peer median of 8.6%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
BNCCEA Industries Inc. Common Stock | LTM Apr 2026 | $179.32M | — | — | 129.3% |
| LTM Mar 2026 | $103.73M | -652.1% | — | 163.3% | |
| LTM Mar 2026 | $64.1M | -32.0% | -47.4% | 2.7% | |
| LTM Mar 2026 | $53.96M | +253.4% | — | 8.1% | |
| LTM Mar 2026 | $49.27M | -45.2% | — | 12.8% | |
| LTM Mar 2026 | $39.26M | +350.8% | — | 7.0% | |
| LTM Mar 2026 | $31.79M | -24.5% | -5.3% | 20.0% | |
| LTM Mar 2026 | $18.56M | -120.7% | -48.5% | 8.6% | |
| LTM Mar 2026 | $8.9M | +128.2% | — | 0.6% | |
| LTM Mar 2026 | $253K | -94.9% | — | — | |
| LTM Mar 2026 | $242K | -99.3% | -66.8% | 0.0% | |
| Peer median (excluding CVEO) | $25.18M | -45.2% | -48.0% | 8.6% | |
Competitors are the stored peer set for CVEO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 2.5M | 6.33M | 30.16M | (18.43M) | (20.08M) |
| Depreciation & Amortization | 83.1M | 87.21M | 75.14M | 68.04M | 72.62M |
| Deferred Income Tax | 3.07M | 4.18M | 6.81M | (7.66M) | (4.41M) |
| Stock-Based Compensation | 4.13M | 3.79M | 4.46M | 2.85M | 3.06M |
| Change in Working Capital | (8.77M) | (13.92M) | (1.57M) | 31.78M | (28.94M) |
| Accounts Receivables | (28.13M) | (14.45M) | (22.31M) | 44.23M | 4.74M |
| Inventory | (526K) | (1.85M) | 5K | (1.22M) | 1.72M |
| Accounts Payables | 15.44M | 12.32M | 7.44M | (17.58M) | (5.19M) |
| Other Working Capital | 4.46M | (9.96M) | 13.3M | 6.36M | (30.21M) |
| Other Non-Cash Items | 4.5M | 4.19M | (18.43M) | 6.93M | 80K |
| Operating Cash Flow | 88.53M | 91.77M | 96.57M | 83.51M | 22.34M |
| Capital Expenditures | (15.57M) | (25.42M) | (31.63M) | (26.14M) | (20.19M) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 14.87M | 16.48M | 17.11M | 11.19M | (69.92M) |
| Investing Cash Flow | (706K) | (8.95M) | (14.52M) | (14.94M) | (90.11M) |
| Debt Repayment | (76.33M) | (33.82M) | (67.75M) | (17.12M) | 132.41M |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | (4.65M) | (44.76M) | (11.63M) | (29.62M) | (53.61M) |
| Dividends Paid | 0 | 0 | (7.42M) | (14.42M) | (3.44M) |
| Other Financing Activities | (5.53M) | (1.08M) | 0 | (4.04M) | (645K) |
| Financing Cash Flow | (86.51M) | (79.66M) | (86.8M) | (65.2M) | 74.72M |
| Effect of Forex Changes | (1.19M) | (1.5M) | 127K | (1.49M) | 2.29M |
| Net Change in Cash | 127K | 1.67M | (4.63M) | 1.88M | 9.24M |
| Free Cash Flow | 72.96M | 66.35M | 64.93M | 57.37M | 2.15M |
Civeo Corporation
NYSE:CVEO
Intrinsic Alpha fair value
Locked
Current Price
$34.36
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.